| Dr Hal Seymour Forman, PHD | |
|
Us Navy Hospital Okinawa, Psc 482, Fpo, AP 96362 | |
| (011) 813-116437555 | |
| Not Available |
| Full Name | Dr Hal Seymour Forman |
|---|---|
| Gender | Male |
| Speciality | Psychologist - Clinical |
| Location | Us Navy Hospital Okinawa, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326028879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | PSY 4385 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hal Seymour Forman, PHD Psc 80 Box 10846, Fpo, AP 96367 Ph: () - | Dr Hal Seymour Forman, PHD Us Navy Hospital Okinawa, Psc 482, Fpo, AP 96362 Ph: (011) 813-116437555 |
News Archive
UCLA scientists have identified two chemicals that convince cells to ignore premature signals to stop producing important proteins. Published in the Sept. 28 edition of the Journal of Experimental Medicine, the findings could lead to new medications for genetic diseases, such as cancer and muscular dystrophy, that are sparked by missing proteins.
A widely-used arthritis drug reduces the incidence of non-melanoma skin cancers - the most common cancers in humans - according to a study published this week in the Journal of the National Cancer Institute. The COX-2 inhibitor celecoxib (brand name Celebrex), which is currently approved for the treatment of osteoarthritis, rheumatoid arthritis and acute pain in adults led to a 62 percent reduction in non-melanoma skin cancers, which includes basal cell carcinomas and squamous cell carcinomas.
The Michael J. Fox Foundation for Parkinson's Research announced awards totaling approximately $10.1 million for five new clinical studies and 14 pre-clinical therapeutic development projects. The funding includes $2.5 million to drive four new clinical trials under the Clinical Intervention Awards, one of the Foundation's Edmond J. Safra Core Programs for PD Research.
Complete Genomics, Inc. announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission relating to the proposed initial public offering of shares of its common stock. The shares of common stock to be sold in this offering are proposed to be sold solely by Complete Genomics, Inc.
› Verified 8 days ago
Daniel Northington, PHD Psychologist Medicare: Medicare Enrolled Practice Location: Nmrtc Okinawa, Psc 482, Fpo, AP 96362 Phone: 805-235-3425 | |
Dr. Odelia Nicole Mcfadden, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Uss Carl Vinson, Unit 100111, Fpo, AP 96629 Phone: 267-709-3521 | |
Allison Conforte, M.ED., ED.S., PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s. Nmrtc Yokosuka, Fpo, AP 96350 Phone: 315-243-8649 | |
Dr. Felecia D. Sheffield, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: Naf Atsugi Bldg 21, Atsugi, Japan, Fpo, AP 96306 Phone: 315-264-3958 | |
Dr. Ivan Ryota Irie, PSYD Psychologist Medicare: Medicare Enrolled Practice Location: Psc 475 Box 1, Fpo, AP 96350 Phone: 315-243-5171 | |
Debra Hoffmann Houst, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: Medical Department, Uss Carl Vinson Cvn 70, Fpo, AP 96629 Phone: 757-953-5814 | |
Eguono Voke Akpoduado, PSY.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: U.s Nmrtc Yokosuka, Naval Hospital, Fpo, AP 96350 Phone: 315-243-8649 |